MRD / Regn No. : SG1185 Date : 23/06/2026
Patient Name : Prakash Shah Age & Gender : 74 Yrs. / Male
Contact No. : 9830059360 UHID :
Ht / Wt / BMI : 166 / 70 / 25.40 BP S / BP D : 132 / 79
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (22/Jun/2013) | HYPERTENSION (22/Jun/2023) |
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 322 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 12.6 % | POST PRANDIAL GLUCOSE (2HPP): 365 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION DEGLUDEC (INJ U100)
TRESIBA
Medicine For DIABETES
SQ 0-0-30 BEDTIME
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
2 ANTIHYPERGLYCEMIC SEMAGLUTIDE 0.25 MG
SEMATRINITY
SC ONCE A WEEK
TILL NEXT VISIT
3 TELMISARTAN 40 MG + AMLODIPINE 5 MG
TELMA AM
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
4 ATORVASTATIN 20 MG
TONACT 20 MG
PO 0-0-1 BEFORE DINNER
TILL NEXT VISIT
5 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN (5MG) + GLIMEPIRIDE (2MG) + METFORMIN (1000MG)
GEMERDAPA 2 MG
PO 1-0-1 BEFORE BREAKFAST AND DINNER
TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 23/Dec/2026
Tests Suggested For Next Visit : HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE,ECG
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: